Related Experiment Video
Updated: Jun 15, 2026

In Vitro Cleavage Assays using Purified Recombinant Drosophila Caspases for Substrate Screening
Published on: October 6, 2022
Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation
Crispin R Dass1, Stuart J Galloway, Peter F M Choong
1Department of Orthopaedics, St. Vincent's Hospital Melbourne, Fitzroy, VIC, Australia. cris.dass@yahoo.com
Abstract:
Signaling pathways for caspase-2-mediated apoptosis are poorly defined. This is partially due to a lack of a reproducible stimulus to trigger caspase-2 activation. We present the oligonucleotide Dz13, a DNA enzyme that cleaves c-Jun mRNA and is capable of inhibiting various model tumors in mice, which potently induces caspase-2 resulting in apoptosis in a panel of tumor cell lines. Dz13-mediated cell death occurred even in the absence of known caspase-2 molecular partners in p53-induced protein with a death domain, RIP-associated Ich-1/CED homologous protein with death domain, or DNA-dependent protein kinase catalytic subunit, or other caspases in cell lines of breast cancer, prostate cancer, osteosarcoma, and liposarcoma. z-VDVAD-fmk, caspase-2(-/-) mouse embryonic fibroblasts and siRNA silencing of caspase-2 in tumor cells abrogated Dz13-mediated cell death. In an orthotopic tumor model, expression of caspase-2 increased as the tumor metastasized and caspase-2 expression was sporadic in patient tumor specimens. These findings provide hope that Dz13, and other agents that evoke activation of caspase-2, may be therapeutic clinically.
Insights
The DNA enzyme Dz13 triggers caspase-2 (an apoptosis-regulating protein) to induce cancer cell death. This discovery offers potential new therapeutic strategies for various tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Caspase-2-mediated apoptosis signaling pathways are not well understood.
- A lack of reproducible stimuli hinders caspase-2 activation research.
Purpose of the Study:
- To investigate the DNA enzyme Dz13 as a potent inducer of caspase-2 activation and apoptosis.
- To explore the therapeutic potential of Dz13 in various cancer cell lines and tumor models.
Main Methods:
- Treatment of tumor cell lines with the oligonucleotide Dz13.
- Assessment of apoptosis induction and caspase-2 activation.
- Validation using caspase-2 deficient cells and siRNA silencing.
- Analysis of caspase-2 expression in an orthotopic tumor model and patient specimens.
Main Results:
- Dz13 potently induced caspase-2-mediated apoptosis across multiple cancer cell lines (breast, prostate, osteosarcoma, liposarcoma).
- Dz13-induced cell death occurred independently of known caspase-2 partners and other caspases.
- Inhibition of caspase-2 abrogated Dz13-mediated cell death.
- Caspase-2 expression correlated with tumor metastasis in an orthotopic model.
Conclusions:
- Dz13 is a novel and effective stimulus for caspase-2 activation, leading to apoptosis in tumor cells.
- Caspase-2 plays a significant role in Dz13-induced tumor cell death.
- Dz13 and other caspase-2 activating agents show promise as clinical cancer therapeutics.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...

